Form 8-K - Current report:
SEC Accession No. 0001640334-26-000461
Filing Date
2026-03-17
Accepted
2026-03-17 16:45:47
Documents
58
Period of Report
2026-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 82116
2 AUDITED FINANCIAL STATEMENTS artl_ex991.htm   iXBRL EX-99.1 511742
3 CONSENT artl_ex231.htm EX-23.1 1829
  Complete submission text file 0001640334-26-000461.txt   3956483

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20260317.xsd EX-101.SCH 47653
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20260317_lab.xml EX-101.LAB 284780
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20260317_cal.xml EX-101.CAL 45012
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20260317_pre.xml EX-101.PRE 240991
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20260317_def.xml EX-101.DEF 148664
63 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 536308
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 26762867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)